Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
Cancer Immunomodulators Market & Pipeline Insight 2020
US$ 2,000.00
... Immunomodulators Cancer Immunomodulators Mechanism Cancer Immunomodulators Clinical Pipeline By Company, Indication & Phase Cancer Immunomodulators Clinical Pipeline: 747 Cancer Immunomodulators Drugs Majority Cancer Immunomodulators in Preclinical Phase: 300 Marketed Cancer Immunomodulators ...
June 2015
1000 pages
Global Cancer Biosimilars Market Opportunity Outlook
US$ 1,800.00
... Cancer Biosimilars Global Cancer Biosimilars Market Dynamics FDA & EMA Guidelines on Development & Marketing of Biosimilars Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase Cancer Biosimilars Clinical Pipeline: 100 Biosimilars Marketed Cancer Biosimilars Clinical Insight Marketed Cancer ...
June 2015
550 pages
Genetic Testing Market Outlook 2020
US$ 1,500.00
... the Global Genetic Testing market will grow at a CAGR of 10% during the forecasted period 2014-2020. The new edition of the report “Genetic Testing Market Outlook 2020”, highlights the market landscape, key contributing drivers of the market, emerging sectors, and the regulatory framework surrounding the genetic testing segment. The ...
May 2015
135 pages
Global Molecular Diagnostics Market Report: 2015 Edition
US$ 700.00
... the molecular diagnostics field. There is also increasing demand for such technologies at the point of care. The report “Global Molecular Diagnostics Market” provides an in-depth analysis of the molecular diagnostics market along ... sequencing and growth in point of care diagnostics. However, the expansion of global molecular diagnostics industry is hindered by challenges in genetic diagnostics and regulatory issues. By combining SPSS Inc ...
May 2015
48 pages
Competitive Intelligence 2015: Leading Chemical Companies Marketing Tactics
US$ 1,960.00
This new report from Venture Planning Group provides leading chemical companies marketing tactics. The analysis presents: Major promotional strategies. ... report include BASF, Dow, DuPont, ExxonMobil, INEOS, Lyondell, Mitsubishi Chemical, SABIC, Shell, and Sinopec. Contains 35 pages
May 2015
35 pages
Competitive Intelligence 2015: Leading Chemical Companies Strategic Directions
US$ 2,280.00
This new report from Venture Planning Group provides leading chemical companies strategic directions. The report presents insightful strategic assessments, ... report include BASF, Dow, DuPont, ExxonMobil, INEOS, Lyondell, Mitsubishi Chemical, SABIC, Shell, and Sinopec. Contains 56 pages
May 2015
56 pages
Competitive Intelligence 2015: Leading Chemical Companies Technological Know-How
US$ 1,960.00
... Venture Planning Group provides leading chemical companies technological know-how. The report presents: Internally developed and acquired chemical and related capabilities ... report include BASF, Dow, DuPont, ExxonMobil, INEOS, Lyondell, Mitsubishi Chemical, SABIC, Shell, and Sinopec. Contains 30 pages
May 2015
30 pages
